Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients

Saved in:
Bibliographic Details
Main Authors: Paul J. Hengeveld, Joyce Schilperoord-Vermeulen, P. Martijn Kolijn, Julie M. N. Dubois, Peter E. Westerweel, Sabina Kersting, Arnon P. Kater, Mark-David Levin, Anton W. Langerak
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01209-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545007620685824
author Paul J. Hengeveld
Joyce Schilperoord-Vermeulen
P. Martijn Kolijn
Julie M. N. Dubois
Peter E. Westerweel
Sabina Kersting
Arnon P. Kater
Mark-David Levin
Anton W. Langerak
author_facet Paul J. Hengeveld
Joyce Schilperoord-Vermeulen
P. Martijn Kolijn
Julie M. N. Dubois
Peter E. Westerweel
Sabina Kersting
Arnon P. Kater
Mark-David Levin
Anton W. Langerak
author_sort Paul J. Hengeveld
collection DOAJ
format Article
id doaj-art-d4c83c6d68ed454293d889cad4c8bbe4
institution Kabale University
issn 2044-5385
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj-art-d4c83c6d68ed454293d889cad4c8bbe42025-01-12T12:08:49ZengNature Publishing GroupBlood Cancer Journal2044-53852025-01-011511510.1038/s41408-025-01209-9Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patientsPaul J. Hengeveld0Joyce Schilperoord-Vermeulen1P. Martijn Kolijn2Julie M. N. Dubois3Peter E. Westerweel4Sabina Kersting5Arnon P. Kater6Mark-David Levin7Anton W. Langerak8Department of Immunology, Laboratory of Medical Immunology, Erasmus MC, University Medical Centre RotterdamDepartment of Immunology, Laboratory of Medical Immunology, Erasmus MC, University Medical Centre RotterdamDepartment of Immunology, Laboratory of Medical Immunology, Erasmus MC, University Medical Centre RotterdamDepartment of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical CentersDepartment of Internal Medicine, Albert Schweitzer HospitalDepartment of Hematology, Haga HospitalDepartment of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical CentersDepartment of Internal Medicine, Albert Schweitzer HospitalDepartment of Immunology, Laboratory of Medical Immunology, Erasmus MC, University Medical Centre Rotterdamhttps://doi.org/10.1038/s41408-025-01209-9
spellingShingle Paul J. Hengeveld
Joyce Schilperoord-Vermeulen
P. Martijn Kolijn
Julie M. N. Dubois
Peter E. Westerweel
Sabina Kersting
Arnon P. Kater
Mark-David Levin
Anton W. Langerak
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Blood Cancer Journal
title Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
title_full Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
title_fullStr Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
title_full_unstemmed Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
title_short Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
title_sort treatment with obinutuzumab plus venetoclax reshapes the trb repertoire of cll patients
url https://doi.org/10.1038/s41408-025-01209-9
work_keys_str_mv AT pauljhengeveld treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT joyceschilperoordvermeulen treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT pmartijnkolijn treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT juliemndubois treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT peterewesterweel treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT sabinakersting treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT arnonpkater treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT markdavidlevin treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients
AT antonwlangerak treatmentwithobinutuzumabplusvenetoclaxreshapesthetrbrepertoireofcllpatients